-
The Economic Burden of Narcolepsy in the United States: Matched Analysis of National Health and Wellness Survey Data
Mar 10, 2025, 14:00 PM -
Superior Performance of Generative AI After Application of Mixture-of-Agents LLMs in Outcomes Research
Mar 10, 2025, 14:00 PM -
Formulary Inclusion for Oncologic Indications: Comparing FDA-Approved Indications and Off-Label Compendia Support
Mar 10, 2025, 14:00 PM -
Examining Burden of Disease and Access to Care in Adults with X-Linked Hypophosphatemia in Brazil
Mar 10, 2025, 14:00 PM -
Disability Progression and Associated Costs in Incident Early-Onset Myasthenia Gravis Patients in France A Longitudinal Cohort Study
Mar 10, 2025, 14:00 PM -
Synthetic Patient Trajectories Using Generative AI on Electronic Health Records
Mar 10, 2025, 14:00 PM -
Navigating Scarcity: Leveraging AI to Address the Challenges of Identifying Rare Disease Key Opinion Leaders
Mar 10, 2025, 14:00 PM -
Survival Analysis in Breast Cancer Patients Treated with Targeted Therapies and Conventional Therapies in the US: A Comparative Real World Study
Mar 10, 2025, 14:00 PM -
Persistence of Infliximab Biosimilar versus Originator in Patients with Crohn's Disease: a Retrospective Cohort Study in China
Mar 10, 2025, 14:00 PM -
Global Analysis of the Epidemiological Burden of Osteoarthritis based on Data from the Global Burden of Disease Study
Mar 10, 2025, 14:00 PM -
Exploring Oral Skeletal Muscle Relaxant Therapy in Adult Poststroke Patients in the US
Mar 10, 2025, 14:00 PM -
A Simple and Practical Guide to Implementing Generalized Risk-Adjusted Cost-Effectiveness (GRACE): A Case Study in Non-Small Cell Lung Cancer
Mar 10, 2025, 14:00 PM -
Clinical Outcomes and Healthcare Resource Utilization in Moderate to Late Preterm Infants With Respiratory Distress Syndrome
Mar 10, 2025, 14:00 PM -
Cost and Prevalence of Pre-Analytical Errors: A Narrative Review
Mar 10, 2025, 14:00 PM -
Are Patients With Major Depressive Disorder (MDD) Getting Access to Innovation in HTA Markets? Review of Reimbursement Decisions of Pharmacotherapies for MDD in Europe, Australia, and Canada From 2001 to 2021
Mar 10, 2025, 14:00 PM -
A Contemporary Analysis of Utilization, Clinical Outcomes and Costs of Robotic-Assisted, Laparoscopic, and Open Partial Nephrectomy Using the National Inpatient Sample
Mar 10, 2025, 14:00 PM -
Adverse Events Associated With Recently Approved Alzheimer's Drugs: A Real-World Pharmacovigilance Study
Mar 10, 2025, 14:00 PM -
Assessing the Proportion of Days Covered within 180 Days after First Medication Fills Among Bipolar Disorder Patients Using Real-World Data
Mar 10, 2025, 14:00 PM -
Understanding Barriers to the Early Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease from the Perspective of Physicians and Patients: Results from a Real-World Survey in Germany
Mar 10, 2025, 14:00 PM -
ActiveSLR: Optimizing efficiency in Systematic Literature Reviews with Artificial Intelligence
Mar 10, 2025, 14:00 PM